Arteris Carries Momentum Into a Quarter Where the Guidance Raise Gets Stress-Tested
Arteris Inc (NASDAQ: AIP) reports second quarter 2026 earnings after market close on August 6, 2026, with analysts expecting continued losses but significant year-over-year improvement. The semiconductor IP company faces a critical test as investors weigh its path toward profitability against a backdrop of strengthening analyst sentiment and volatile post-earnings price action.
Part 1: Earnings Preview
Arteris Inc is a semiconductor intellectual property (IP) provider specializing in system-on-chip (SoC) interconnect solutions that enable faster, more efficient chip designs for applications ranging from automotive to artificial intelligence. The company serves a global customer base of chip designers and system companies requiring advanced on-chip communication technology.
Arteris is scheduled to report Q2 2026 results after market close on August 6, 2026. Analysts expect an EPS loss of $-0.17 on revenue estimates around $23.5 million according to web search data. The company most recently reported Q1 2026 results on May 12, 2026, posting an actual EPS of $-0.15.
Compared to the same quarter last year when Arteris reported $-0.21 per share, the current consensus represents 19% improvement year-over-year, signaling meaningful progress in the company's journey toward profitability. The estimate range spans from $-0.18 to $-0.15, reflecting relatively tight analyst alignment.
Three key themes define this earnings story:
Revenue Growth Acceleration: With consensus revenue estimates of $23.5 million representing over 42% year-over-year growth from Q2 2025's $16.5 million, investors will scrutinize whether Arteris can sustain this momentum. The company's guidance of $23.0-24.0 million for Q2 suggests management confidence in continued expansion.
Path to Profitability: The narrowing losses—from $-0.21 per share in Q2 2025 to an expected $-0.17 this quarter—represent the central question for investors. With full-year 2026 estimates of $-0.60 improving to $-0.40 for 2027, the trajectory toward breakeven is critical for validating the company's business model scalability.
Semiconductor IP Market Positioning: As AI and automotive applications drive demand for advanced chip interconnect technology, Arteris's ability to capitalize on these secular trends while managing operating leverage will determine whether the company can meet increasingly optimistic analyst expectations. Recent analyst upgrades suggest growing confidence in the company's competitive position.
Analyst commentary ahead of the release has turned notably bullish, with the average recommendation improving to 4.43 from 4.20 a month ago, and five analysts now rating the stock a Strong Buy compared to three previously. The consensus price target of $38.20 implies significant upside potential, reflecting optimism about the company's growth trajectory and market opportunity in the expanding semiconductor IP space.
Part 2: Historical Earnings Performance
Arteris has demonstrated a clear pattern of beating earnings estimates over the past four quarters, with the company exceeding consensus in three of the last four reports. The most recent quarter (Q1 2026) showed the strongest performance, with actual EPS of $-0.15 beating estimates of $-0.19 by 21.05%—the largest surprise in the recent history.
The trend shows accelerating positive momentum. After meeting estimates exactly in Q2 2025 (both actual and estimated at $-0.21), the company posted progressively larger beats: +4.76% in Q3 2025, +15.79% in Q4 2025, and +21.05% in Q1 2026. This pattern suggests improving operational execution and potentially conservative guidance from management.
The magnitude of losses has also narrowed consistently, declining from $-0.21 four quarters ago to $-0.15 last quarter. This steady improvement in absolute EPS performance, combined with the pattern of beating estimates by widening margins, indicates the company is executing better than analysts anticipated and making tangible progress toward profitability. Investors will watch whether this positive trend continues into Q2 2026.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $-0.21 | $-0.21 | unch | Beat |
| Sep 2025 | $-0.21 | $-0.20 | +4.76% | Beat |
| Dec 2025 | $-0.19 | $-0.16 | +15.79% | Beat |
| Mar 2026 | $-0.19 | $-0.15 | +21.05% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Arteris reports after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual earnings data.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-12 | -$0.70 (-2.11%) | $1.87 (5.64%) | +$3.12 (+9.62%) | $5.71 (17.61%) |
| 2026-02-12 | -$0.18 (-1.19%) | $0.91 (6.06%) | -$0.30 (-2.01%) | $1.89 (12.70%) |
| 2025-11-04 | -$0.77 (-5.88%) | $0.96 (7.33%) | +$3.21 (+26.06%) | $1.90 (15.42%) |
| 2025-08-05 | +$3.55 (+37.57%) | $1.99 (21.06%) | -$3.12 (-23.96%) | $1.17 (9.00%) |
| 2025-05-13 | +$0.48 (+6.10%) | $0.69 (8.72%) | -$0.84 (-10.06%) | $1.26 (15.09%) |
| 2025-02-18 | +$0.38 (+3.89%) | $0.51 (5.23%) | -$0.15 (-1.48%) | $1.40 (13.86%) |
| 2024-11-05 | +$0.39 (+5.76%) | $0.70 (10.34%) | +$1.34 (+18.72%) | $1.12 (15.57%) |
| 2024-08-01 | -$0.59 (-7.20%) | $0.77 (9.39%) | -$0.12 (-1.58%) | $0.83 (10.92%) |
| Avg Abs Move | 8.71% | 9.22% | 11.69% | 13.77% |
Arteris exhibits highly volatile post-earnings price behavior, with an average absolute Day 0 move of 8.71% and Day +1 move of 11.69%—both substantially above typical market reactions. The Day +1 moves are particularly dramatic, ranging from a 26.06% surge following Q3 2025 results to a 23.96% decline after Q2 2025 earnings.
The direction of moves has been unpredictable, with no consistent pattern of post-earnings gains or losses. Recent quarters show wild swings: Q2 2025 saw a massive 37.57% Day 0 spike followed by a 23.96% Day +1 reversal, while Q3 2025 dropped 5.88% on Day 0 before surging 26.06% on Day +1. The most recent Q1 2026 report showed relative calm with a 2.11% Day 0 decline followed by a 9.62% Day +1 recovery.
Investors should prepare for significant volatility around this earnings release. The historical average suggests moves exceeding 10% are common, and the wide intraday ranges (averaging 9.22% on Day 0 and 13.77% on Day +1) indicate substantial two-way price action regardless of initial direction.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 16) |
| Expected Move | $5.06 (16.06%) |
| Expected Range | $26.43 to $36.55 |
| Implied Volatility | 110.62% |
The options market is pricing a 16.06% expected move for the August 21 expiration, which is notably higher than the historical average Day +1 move of 11.69% but below some of the more extreme historical reactions. This suggests options traders are anticipating above-average volatility but not the 20%+ swings seen in several recent quarters. The elevated implied volatility of 110.62% reflects significant uncertainty about the earnings outcome and subsequent price action.
Part 3: What Analysts Are Saying
Analysts have turned decisively bullish on Arteris heading into earnings, with the current consensus rating of 4.43 (Strong Buy territory) representing a significant improvement from 4.20 just one month ago. The sentiment trend has improved, driven by two additional analysts upgrading to Strong Buy positions.
The analyst breakdown shows 5 Strong Buy ratings, 0 Moderate Buys, and 2 Hold ratings among the 7 analysts covering the stock, with zero sell ratings. This represents a notable shift from a month ago when only 3 analysts rated the stock a Strong Buy, indicating growing conviction in the company's prospects.
The consensus price target of $38.20 implies 23.5% upside from the current price of $30.93, with the range spanning from a low of $35.00 to a high of $40.00. The tight clustering of price targets (only $5.00 spread) suggests strong agreement among analysts about the company's valuation, while the meaningful upside potential reflects optimism about Arteris's ability to execute on its growth strategy and continue narrowing losses toward profitability.
Part 4: Technical Picture
The Barchart Technical Opinion currently shows a Buy signal at 40%, representing a significant strengthening from 24% one week ago but a pullback from 56% one month ago. This suggests recent consolidation after a stronger technical setup in early July.
Timeframe Analysis:
- Short-term (Hold): Neutral signal indicates near-term momentum has stalled, suggesting caution for immediate positioning ahead of earnings
- Medium-term (50% Buy): Moderate buy signal reflects balanced intermediate-term momentum with neither bulls nor bears in clear control
- Long-term (100% Buy): Strong buy signal indicates the longer-term trend remains firmly positive despite recent consolidation
Trend Characteristics: The trend shows Average strength with the Weakest directional momentum, suggesting the stock is in a consolidation phase within an overall uptrend heading into the earnings release.
The stock is trading above its 5-day ($30.46), 10-day ($30.21), 100-day ($30.04), and 200-day ($22.68) moving averages, but below its 20-day ($31.62) and 50-day ($36.09) averages. This mixed picture indicates the stock has pulled back from recent highs near $36 but maintains support above longer-term trend lines.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $30.46 | 50-Day MA | $36.09 |
| 10-Day MA | $30.21 | 100-Day MA | $30.04 |
| 20-Day MA | $31.62 | 200-Day MA | $22.68 |
The technical setup presents a mixed picture heading into earnings. While the long-term trend remains constructive with the stock well above its 200-day moving average, the recent decline from the 50-day average at $36.09 and the weakening short-term momentum suggest limited technical support for a pre-earnings rally. The stock's position just below the 20-day moving average at $31.62 makes that level a key near-term resistance, while support appears around the $30 level where multiple shorter-term averages converge. Given the historical volatility around Arteris earnings and the current consolidation pattern, the technical setup is cautiously neutral—neither strongly supportive nor particularly bearish—placing greater emphasis on the fundamental results and guidance to determine the next directional move.